Gene expression signatures of circulating human type 1, 2, and 3 innate lymphoid cells - 06/06/19
Doi : 10.1016/j.jaci.2019.01.047
Shuo Li, PhD a, b, c 
, Hideaki Morita, MD, PhD b, d, e, Milena Sokolowska, MD, PhD b, Ge Tan, PhD b, f, Tadech Boonpiyathad, MD, MSc b, d, g, Lennart Opitz, MSc f, Keisuke Orimo, MD e, Stuart K. Archer, PhD h, Kirstin Jansen, MSc b, Mimi L.K. Tang, MBBS, PhD i, Damian Purcell, PhD a, ∗, Magdalena Plebanski, PhD j, ∗, Cezmi A. Akdis, MD b, ∗
, Hideaki Morita, MD, PhD b, d, e, Milena Sokolowska, MD, PhD b, Ge Tan, PhD b, f, Tadech Boonpiyathad, MD, MSc b, d, g, Lennart Opitz, MSc f, Keisuke Orimo, MD e, Stuart K. Archer, PhD h, Kirstin Jansen, MSc b, Mimi L.K. Tang, MBBS, PhD i, Damian Purcell, PhD a, ∗, Magdalena Plebanski, PhD j, ∗, Cezmi A. Akdis, MD b, ∗ a Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Australia
b Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland
c Department of Pathology, Monash University, Clayton, Australia
d Christine Kühne-Center for Allergy Research and Education, Davos, Switzerland
e Department of Allergy and Clinical Immunology, National Research Institute for Child Health and Development, Tokyo, Japan
f Functional Genomics Center Zurich, ETH Zurich/University of Zurich, Zurich, Switzerland
g Department of Medicine, Phramongkutklao Hospital, Bangkok, Thailand
h Monash Bioinformatics Platform, Monash University, Clayton, Australia
i Murdoch Children's Research Institute, the Royal Children's Hospital, and the University of Melbourne, Melbourne, Australia
j School of Health and Biomedical Sciences, RMIT University, Melbourne, Australia
| Supported by Swiss National Science Foundation grant no. 310030_156823; NHMRC program grant APP1052979. M.P. is the recipient of an NHMRC Senior Research Fellowship. |
|
| Disclosure of potential conflict of interest: C. A. Akdis reports grants from Allergopharma, Actellion, the Swiss National Science Foundation, the Christine Kühne-Center for Allergy Research and Education, and the European Commission's Horizon's 2020 Framework Programme Cure outside the submitted work. The rest of the authors declare that they have no relevant conflicts of interest. |
© 2019
Publié par Elsevier Masson SAS.
Vol 143 - N° 6
P. 2321-2325 - juin 2019 Retour au numéro
Article précédent
- F-BAR domain only protein 1 (FCHO1) deficiency is a novel cause of combined immune deficiency in human subjects
- Enrica Calzoni, Craig D. Platt, Sevgi Keles, Hye Sun Kuehn, Sarah Beaussant-Cohen, Yu Zhang, Julia Pazmandi, Gaetana Lanzi, Francesca Pala, Azzeddine Tahiat, Hasibe Artac, Raul Jimenez Heredia, Jasmin Dmytrus, Ismail Reisli, Vedat Uygun, Dilara Uygun, Aysen Bingol, Erdem Basaran, Kamel Djenouhat, Nafissa Benhalla, Chafa Bendahmane, Melike Emiroglu, Tomas Kirchhausen, Mithun Pasham, Jennifer Jones, Jacqueline G. Wallace, Lixin Zheng, Bertrand Boisson, Fulvio Porta, Sergio D. Rosenzweig, Helen Su, Silvia Giliani, Michael Lenardo, Raif S. Geha, Kaan Boztug, Janet Chou, Luigi D. Notarangelo
- The MALT1 locus and peanut avoidance in the risk for peanut allergy
- Alexandra Winters, Henry T. Bahnson, Ingo Ruczinski, Meher P. Boorgula, Claire Malley, Ali R. Keramati, Sameer Chavan, David Larson, Karen Cerosaletti, Peter H. Sayre, Marshall Plaut, George Du Toit, Gideon Lack, Kathleen C. Barnes, Gerald T. Nepom, Rasika A. Mathias, Immune Tolerance Network LEAP Study Team
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?